Javier Martín-Broto Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

10/2019

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Martín-Broto Research Topics

Disease

23	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 01/2012
17	Neoplasms (Cancer) 03/2024 - 01/2012
6	Leiomyosarcoma 12/2022 - 01/2012
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2023 - 07/2015
4	Synovial Sarcoma (Synovioma) 11/2020 - 01/2012
3	Liposarcoma 12/2022 - 01/2015
2	Disease Progression 11/2023 - 09/2022
2	Giant Cell Tumor of Tendon Sheath 01/2023 - 08/2021
2	Pain (Aches) 01/2023 - 03/2005
2	Nausea 09/2022 - 10/2019
2	Fatigue 09/2022 - 10/2019
2	Adenocarcinoma 09/2020 - 01/2016
1	Rhabdomyosarcoma 01/2023
1	Pigmented Villonodular Synovitis 01/2023
1	Giant Cell Tumors (Giant Cell Tumor) 01/2023
1	Febrile Neutropenia 10/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2022
1	Solitary Fibrous Tumors 09/2022
1	Vomiting 09/2022
1	Myxoid Liposarcoma 09/2022
1	Cardiotoxicity 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 09/2020
1	Dysgeusia (Parageusia) 10/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015
1	Necrosis 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Glioblastoma (Glioblastoma Multiforme) 12/2004

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 01/2012
9	TrabectedinIBA 09/2022 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
3	olaratumabIBA 03/2024 - 01/2021
3	pexidartinibIBA 01/2023 - 10/2019
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2012
3	CateninsIBA 11/2021 - 01/2017
3	Imatinib Mesylate (Gleevec)FDA Link 02/2020 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2023 - 07/2015
2	Gemcitabine FDA Link 12/2022 - 01/2018
2	Ifosfamide FDA LinkGeneric 10/2022 - 01/2015
2	AnthracyclinesIBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2014
2	RG7112IBA 08/2015 - 01/2015
2	multidrug resistance-associated protein 1IBA 04/2014 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2014 - 01/2012
1	RNA (Ribonucleic Acid)IBA 03/2024
1	HMGB1 Protein (HMG1)IBA 01/2023
1	PlatinumIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Narcotics (Narcotic Analgesics)IBA 01/2023
1	eribulin FDA Link 12/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	A-Form DNA (A-DNA)IBA 12/2021
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	LigandsIBA 01/2021
1	talimogene laherparepvecIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	ICG 001IBA 09/2020
1	olaparibIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019
1	Macrophage Colony-Stimulating FactorIBA 10/2019
1	Mitogen-Activated Protein Kinase 3IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Cytotoxins (Cytolysins)IBA 06/2017
1	TriterpenesIBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Ursolic AcidIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	maslinic acidIBA 04/2014
1	nilotinib FDA Link 01/2012
1	Therapeutic UsesIBA 01/2012
1	Estramustine FDA Link 03/2005
1	Hormones (Hormone)IBA 03/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2005
1	Temozolomide (Temodar)FDA LinkGeneric 12/2004
1	Cisplatin (Platino)FDA LinkGeneric 12/2004

Therapy/Procedure

9	Therapeutics 11/2023 - 07/2015
5	Drug Therapy (Chemotherapy) 11/2023 - 03/2005
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2022
1	Immunotherapy 11/2020
1	Neoadjuvant Therapy 01/2015
1	Aftercare (After-Treatment) 01/2015
1	Complementary Therapies (Alternative Medicine) 01/2012
1	Radiotherapy 12/2004